-
公开(公告)号:BRPI0915825A2
公开(公告)日:2015-11-03
申请号:BRPI0915825
申请日:2009-07-08
Applicant: ABBOTT LAB
Inventor: MURTAZA ANWAR , HUTCHINS CHARLES W , HSIEH CHUNG-MING , TARCSA EDIT , BELANGER EILEEN , SHEN JIANWEI , GU JIJIE , HARRIS MARIA C , ZHU RONG-RONG , STINE WILLIAM B
IPC: A61K39/395
-
公开(公告)号:NZ600979A
公开(公告)日:2014-01-31
申请号:NZ60097909
申请日:2009-01-15
Applicant: ABBOTT LAB
Inventor: HSIEH CHUNG-MING
IPC: C12N15/00
Abstract: 600979 Disclosed is an expression vector comprising: (a) an OriP origin of replication derived from Epstein-Barr virus (EBV); (b) an SV40 origin of replication; (c) an insertion site for inserting a gene of interest; (d) a promoter operably linked to the insertion site, wherein the promoter is a cytomegalovirus (CMV) promoter; and, optionally, (e) a nucleic acid sequence encoding an antibody heavy or light chain constant region, operably linked to the insertion site, wherein the OriP origin of replication is bound by a trans-acting EBNA1 replication initiation factor that is not encoded by the expression vector, or the SV40 origin of replication is bound by a trans-acting SV40 T antigen that is not encoded by the expression vector.
-
公开(公告)号:NZ587766A
公开(公告)日:2013-06-28
申请号:NZ58776609
申请日:2009-03-03
Applicant: ABBOTT LAB
Inventor: HSIEH CHUNG-MING , BELK JONATHAN P , PEREZ JENNIFER M , BENATUIL LORENZO
Abstract: NZ 587766 Disclosed is a method of preparing a yeast library by electroporation of yeast cells, the method comprising the steps of: incubating the yeast cells in a solution comprising lithium acetate (LiAc) and dithiothreitol (DTT); providing a suspension comprising vector DNA, insert DNA, yeast cells, 0.1 to 10 M sorbitol, and 0.1 to 10 mM CaCl2 or MgCl2; and electroporating the suspension at 0.5kV/cm to greater than 12.5kV/cm with a capacitance of about 10 to about 50 mu ?F.
-
公开(公告)号:SG188846A1
公开(公告)日:2013-04-30
申请号:SG2013016084
申请日:2009-03-03
Applicant: ABBOTT LAB
Inventor: HSIEH CHUNG-MING , BELK JONATHAN P , PEREZ JENNIFER M , BENATUIL LORENZO
Abstract: Methods for Transforming Yeast AbstractThis invention is directed to the transformtion of yeast, and mutants thereof, by electroporation, which result in stably transformed yeast host cells that express recombinant products. This invention also is directed to transformed yeast cells and libraries.Figure I
-
公开(公告)号:SG188142A1
公开(公告)日:2013-03-28
申请号:SG2013010228
申请日:2009-05-08
Applicant: ABBOTT GMBH & CO KG , ABBOTT LAB
Inventor: GU JIJIE , HSIEH CHUNG-MING , WU ZHEN , DIGIAMMARINO ENRICO L , LUO FENG , FOX GERARD B , HARLAN JOHN E , SCHMIDT MARTIN , LOEBBERT RALF , MUELLER REINHOLD , EBERT ULRICH , NIMMRICH VOLKER
Abstract: The present application relates to isolated proteins, particularly monoclonal antibodies, in particular CDR-grafted, humanized antibodies which bind to RAGE protein. Specifically, these antibodies have the ability to inhibit the binding of RAGE to its various ligands. The antibodies or portions thereof of described in the present application are useful for treating a disease or disorder characterized by or induced by pathophysiological ligands of RAGE, for example missfolded proteins like amyloid and advanced glycation-end-products.No suitable figure
-
公开(公告)号:DOP2011000274A
公开(公告)日:2011-10-31
申请号:DO2011000274
申请日:2011-09-02
Applicant: ABBOTT LAB
Inventor: LEDDY MARY R , HSIEH CHUNG-MING , HUGUNIN MARGARET , MURTAZA ANWAR , MCRAE BRADFORD L , KUTSKOVA YULIYA , MEMMOT JOHN E , PEREZ JENNIFER M , ZHONG SUJU , TARCSA EDIT , CLABBERS ANCA , WALLACE CRAIG , BRYANT SHAUGHN H
Abstract: Proteínas de unión a IL-17 y/o IL-17F, su uso en composiciones y métodos para el tratamiento, prevención, y diagnóstico de enfermedades relacionadas con IL-17 y para detectar IL-17 en células, tejidos, muestras y composiciones.
-
公开(公告)号:MX2010014573A
公开(公告)日:2011-09-16
申请号:MX2010014573
申请日:2010-12-21
Applicant: ABBOTT LAB
Inventor: HUTCHINS CHARLES W , HSIEH CHUNG-MING , GU JIJIE , ZHU RONG-RONG , SHEN JIANWEI , HARRIS MARIA C , BELANGER EILEEN , MURTAZA ANWAR , TARCSA EDIT , STINE WILLIAM B
IPC: A61K39/395
Abstract: La presente invención abarcar proteínas de unión de prostaglandina E2 (PGE2). La invención se refiere a anticuerpos que son de tipo silvestre, quiméricos, de CDR injertada y humanizados. Los anticuerpos preferidos tienen alta afinidad para prostaglandina E2 y neutralizan la actividad de prostaglandina E2 in vitro e in vivo. Un anticuerpo de la invención puede ser un anticuerpo de longitud completa, o una porción de unión a antígeno del mismo. También se proporcionan métodos para hacer y métodos para utilizar los anticuerpos de la invención. Los anticuerpos, o porciones de unión a antígeno, de la invención son útiles para detectar prostaglandina E2 y para inhibir la actividad de prostaglandina E2, por ejemplo, en un ser humano que sufre de un trastorno en donde la actividad de prostaglandina E2 es dañina.
-
公开(公告)号:SG172855A1
公开(公告)日:2011-08-29
申请号:SG2011049012
申请日:2010-01-29
Applicant: ABBOTT LAB
Inventor: HSIEH CHUNG-MING , WU CHENGBIN
Abstract: The present invention encompasses IL-1α binding proteins. Specifically, the invention relates to antibodies that are chimeric, CDR grafted and humanized antibodies. Antibodies of the invention have high affinity for IL-1α and neutralize IL-1α activity. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Method of making and method of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting IL-1α and for inhibiting IL-1α activity, e.g., in a human subject suffering from a disorder in which IL-1α activity is detrimental.
-
公开(公告)号:AU2009245354A1
公开(公告)日:2009-11-12
申请号:AU2009245354
申请日:2009-05-08
Applicant: ABBOTT GMBH & CO KG , ABBOTT LAB
Inventor: GU JIJIE , HSIEH CHUNG-MING , NIMMRICH VOLKER , LOEBBERT RALF , DIGIAMMARINO ENRICO L , EBERT ULRICH , MUELLER REINHOLD , SCHMIDT MARTIN , LUO FENG , FOX GERARD B , HARLAN JOHN E , WU ZHEN
Abstract: The present application relates to isolated proteins, particularly monoclonal antibodies, in particular CDR-grafted, humanized antibodies which bind to RAGE protein. Specifically, these antibodies have the ability to inhibit the binding of RAGE to its various ligands. The antibodies or portions thereof of described in the present application are useful for treating a disease or disorder characterized by or induced by pathophysiological ligands of RAGE, for example misfolded proteins like amyloid ß and advanced glycation-end-products.
-
">
公开(公告)号:BR112012004546A2
公开(公告)日:2016-11-29
申请号:BR112012004546
申请日:2010-08-27
Applicant: ABBOTT LAB
Inventor: HSIEH CHUNG-MING , BOGHAERT ERWIN R , GU JIJIE , HICKSON JONATHAN A , BENATUIL LORENZO , HARRIS MARIA , MORGAN-LAPPE SUSAN , LI YINGCHUN , KUTSKOVA YULIYA , LIU ZHIHONG
IPC: C07K16/28
-
-
-
-
-
-
-
-
-